Articles tagged "Kidney transplantation"

2015 American Transplant Congress
Kidney Transplantation from Expanded Criteria Deceased Donors With Terminal Acute Kidney Injury
J. Hwang,¹ M.-H. Kim,¹ K. Jun,¹ S. Ahn,¹ S. Kim,¹ S. Park,¹ S. Kim,² J. Kim,¹ C. Yang,² I. Moon.¹
¹Surgery, The catholic University of Korea, Seoul, Korea; ²Internal Medicine, The catholic iniversity of Korea, Seoul, Korea.
We investigated clinical outcomes of kidney transplantation (KT) from deceased donors with terminal acute kidney injury (AKI) defined acute kidney injury network (AKIN) criteria and…
2015 American Transplant Congress
Opportunities in Tacrolimus Therapeutic Drug Monitoring
N. Jandovitz, J. Lee, S. Hammad, J. McKeen, S. Martin, D. Tsapepas.
Department of Pharmacy, NewYork-Presbyterian Hospital, NY.
Tacrolimus requires diligent therapeutic drug monitoring (TDM) to maintain appropriate serum concentrations after transplant. To optimize efficacy & minimize toxicity frequent levels are drawn, commonly…
2015 American Transplant Congress
The Use of Bortezomib for Desensitization in ABO Incompatible and Positive Crossmatch Kidney Transplant
J. Benken,¹ S. Akkina,² E. Benedetti.³
¹Pharmacy Practice, Univ. of IL-Chicago, Chicago, IL; ²Dept. of Medicine, Nephrology, Univ. of IL-Chicago, Chicago, IL; ³Dept. of Surgery, Univ. of IL-Chicago, Chicago, IL.
Introduction:ABO incompatible (ABOi) and positive crossmatch (PXM) living donor kidney transplantation is a life-saving alternative to dialysis. A variety of protocols exist utilizing plasmapheresis (PP)…
2015 American Transplant Congress
Landscape of Non-Directed Live Donors
K. Kumar, X. Luo, A. Massie, T. Purnell, J. Tonascia, E. King, D. Segev.
Johns Hopkins, Baltimore, MD.
Background: The use of kidneys from Non-directed live donors (NDLD) among transplant centers in the US is unknown and the recipient selection remains varied. We…
2015 American Transplant Congress
Ligation of the Native Ureter for Treatment of Urinary Fistula in Kidney Transplantation: Is It Safe?
C. Batagello, K. Yamaçake, R. Falci, H. Kanashiro, R. Kato, G. Ebaid, A. Piovesan, W. Nahas.
Division of Urology, Renal Transplantation Unit, University of Sao Paulo, Sao Paulo, Brazil.
Purpose: Urinary fistula and ureteral stenosis occur respectively in 2-5% and 2-7.5% after kidney transplantation. Within the different causes of stenosis and fistula after kidney…
2015 American Transplant Congress
Alterations in Peripheral Blood B Cell Subpopulations in Kidney Transplant Recipients With DSA
B. Ramaswami,¹ R. Ippolito,² B. Elinoff,¹ M. Marrari,³ K. Hadi,¹ C. Macedo,¹ D. Metes,¹ A. Shields,⁴ R. Alloway,⁵ A. Zeevi,³ F. Lakkis,¹ E. Woodle,⁴ G. Chalasani.^1,2
¹Surgery & STI(1), Medicine(2), Pathology(3), University of Pittsburgh, Pittsburgh; ²Surgery(4) & Medicine(5), University of Cincinnati College of Medicine, Cincinnati.
Peripheral blood B cell subpopulations were assessed over time (1, 3, 6, 9, and 12 months) in living donor kidney transplant recipients undergoing thymoglobulin (n…
2015 American Transplant Congress
Comprehensive Study of 3 Nomenclatures to Discriminate CD8 Subsets in Healthy Volunteers and in Kidney Transplant Recipients
M. Yap,^1,3 G. Tilly,^1,3 M. Giral,^1,2 S. Brouard,^1,2 N. Degauque.^1,2
¹UMR 1064, INSERM, Nantes, France; ²ITUN, CHU de Nantes, Nantes, France; ³Faculté de Médecine, Université de Nantes, Nantes, France.
Objective. Historical classification to distinguish central memory (CM), naïve, effector memory (EM), and terminally-differentiated effector memory (TEMRA) CD8 T cells is based on CD45RA and…
2015 American Transplant Congress
Divergence in Risk Factors for Graft Loss and Death Across Race May Mediate Kidney Transplant Outcome Disparity
M. Posadas Salas,¹ D. Taber,² M. Kamel,¹ M. Kadian,¹ M. Salazar,¹ P. Mohan,¹ T. Srinivas.¹
¹Department of Medicine, Medical University of South Carolina, Charleston, SC; ²Department of Surgery, Medical University of South Carolina, Charleston, SC.
Differences in outcomes between African American and non-African American kidney transplant recipients may reflect disparate access to health care. Minimizing this disparity demands a deeper…
2015 American Transplant Congress
Non-Invasive Immune Monitoring Assay in Transplant Recipients
M. Gasser,¹ I. Tsaur,² K. Lopau,¹ C. Germer,¹ A. Chandraker,³ A. Waaga-Gasser.¹
¹Department of Surgery I, University of Wuerzburg, Wuerzburg, Germany; ²Department of Urology, University of Frankfurt, Frankfurt, Germany; ³Transplantation Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
A reliable non-invasive assay of immune responsiveness would help to predict the development of chronic rejection, stable function or tolerance in transplant recipients. Our aim…
2015 American Transplant Congress
Pharmacokinetics of Everolimus (EVL) in Elderly Recipients Under Low-Tacrolimus(TAC)/Everolimus in the First Year After Renal Transplantation. Data from the NEverOLd Trial
E. David-Neto,¹ P. Romano,² F. Agena,¹ P. Ebner,² A. Triboni,¹ F. Ramos,¹ N. Galante,¹ F. Lemos.¹
¹Renal Transplantation Service, Hospital das Clinicas – University of São Paulo School of Medicine, Sao Paulo, Brazil; ²Division of Central Laboratory, Hospital das Clinicas – University of São Paulo School of Medicine, Sao Paulo, Brazil.
Elderly ( >60 years) recipients are being renal transplanted more frequently. The pharmacokinetics studies (PK) of immunosuppressive drugs in healthy volunteers, rarely, if ever, include…